Press Releases

Ÿnsect obtains market approval for an insect-based fertilizer

17 juin 2020 – Ÿnsect has just gained approval for its natural insect fertilizer “ŸnFrass” issued by ANSES, the French Agency for Food, Environmental and Occupational Health & Safety. Ÿnsect thus becomes the first company in the world to obtain certification and marketing approval for a natural insect-based fertilizer.

17 June 2020

AB Science : masitinib’s potential mode of action in Alzheimer’s Disease

July 08, 2020 – AB Science SA announced the publication of preclinical study results with masitinib in Alzheimer’s disease entitled, ‘Effects of chronic masitinib treatment in APPPS1dE9 transgenic mice modeling Alzheimer’s disease’.

8 July 2020

Algentech Granted US Patent For A Key Genome Editing Technology

16 janvier 2020- Algentech annonce la délivrance d'un brevet clé dans le domaine de l'édition du génome par l'Office des brevets des États-Unis

16 January 2020

IntegraGen renews its agreement with the Institut Pasteur

11 mars 2020 – IntegraGen announces the renewal of its partnership agreement with the Institut Pasteur until December 2021 related to high-throughput sequencing operations for microbiology activities carried out at the Institut Pasteur

11 March 2020

Enalees announces clinical trial for a COVID-19 test

16 septembre 2020 – C4Diagnostics, Bertin Technologies and Enalees announced the launch of a prospective clinical trial for BEC-SARS-CoV-2 for humans, a rapid, point-of-care diagnostic for COVID-19.

16 September 2020

Pharnext – A novel strategy to rapidly reposition drugs using existing COVID-19 clinical data

23 mars 2020 – Pharnext annonce l’identification de 97 médicaments fréquemment prescrits, au moyen de sa plateforme de Pleotherapy, comme candidats potentiels au repositionnement dans le traitement du COVID-19.

23 March 2020

Genopole earns EU|BIC certification

5 décembre 2020 The European Commission's European Business Network (EBN) voted unanimously to certify Genopole as a European Union | Business and Innovation Center (EU|BIC), thus recognizing France's leading biocluster as a key contributor to R&D and Innovation in Genomics in France and Europe.

5 December 2020

A Friendly Takeover Bid Initiated by OncoDNA on IntegraGen

July 09, 2020 This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both companies would enable to offer a complete solution that combines oncology laboratory testing and software solutions which will benefit the treatment of patients with advanced cancer.

9 July 2020

Gene.iO 2023 – 8 award-winning innovative biotechs

October 16, 2023 – 8 innovative biotech companies have just been selected in the 3rd promotion of Genopole's Gene.iO program: they win a year's coaching at the cutting edge of biotech expertise, to help them successfully raise their first funds or sign their first commercial agreement.

16 October 0203

Genopole’s D4MedTech project chosen by the Tiers-Lieux d’Expérimentation call for projects

Project-leader Genopole and the D4MedTech consortium members are proud to be laureates of the call for projects Tiers-Lieux d’Expérimentation for eHealth, a part of the France 2030 national strategy. The D4MedTech project will create an environment for the research and development of digital innovations in diabetology.

05 December 2024

Gold medal for the Genopole Évry Paris-Saclay team at iGEM 2024

the Évry Paris-Saclay team won gold with PHAGEVO, a project focused on the directed evolution of proteins to better detect compounds resulting from plastics degradation.

05 November 2024

Enalees launches the Astéria kit for coronavirus diagnosis in cats

17 October 2024 – Enalees, a leader in veterinary molecular diagnostics, announced today the launch of their new Astéria Feline Coronavirus kit for the rapid and accurate diagnosis of coronaviruses in cats.

17 October 2024

Genopole reveals the laureates of the 2024 Shaker and Gene.iO programs

During a recent Welcome Session event held to present newcomers to the biocluster, Genopole announced the ten candidates retained for the 15th edition of its Shaker accompaniment program and the 4th edition of its Gene.iO acceleration program, designed to enable success for an initial fund-raising campaign or commercial agreement.

09 October 2024

Four Genopole-accompanied start-ups, laureates of the i-Lab innovation competition

Four companies affiliated with Genopole, bYoRNA, CGenetix, endogene.bio (health) and Fungu'it (foodtech), are bringing home i-Lab prizes attesting to the pertinence and solidity of their innovations. The i-Lab competition recognizes the most-promising deep-tech start-ups and contributes to their growth by providing up to €600,000 in financial assistance.

04 October 2024

Genopole launches APROVALS, a European project for cellular agriculture

Launched in September 2024 for a period of 2.5 years and coordinated by Genopole, the APROVALS project aims to facilitate the deployment and integration of emerging technologies in the field of cellular agriculture by implementing a testing environment that serves innovators throughout the development process of their products

25 September 2024